ResearcherCancer Research UK Scotland InstituteNo recent work listed

James Drew

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2864-7987; OpenAlex author ID A5036637335. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 2 papers

Papers 2

Collagen VI expression is negatively mechanosensitive in pancreatic cancer cells and supports the metastatic niche. First author DOI 10.1242/jcs.259978 ↗
A conserved transcriptional signature supports metastatic colonisation of the liver by pancreatic cancer cells Co-author DOI 10.21203/rs.3.rs-1635604/v1 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Laura M. Machesky · 2 shared papers, 2022 · strength 0.49
- Paper A conserved transcriptional signature supports metastatic colonisation of the liver by pancreatic cancer cells DOI 10.21203/rs.3.rs-1635604/v1 ↗
- Paper Collagen VI expression is negatively mechanosensitive in pancreatic cancer cells and supports the metastatic niche. DOI 10.1242/jcs.259978 ↗
Amélie Juin · 1 shared paper, 2022 · strength 0.16
- Paper Collagen VI expression is negatively mechanosensitive in pancreatic cancer cells and supports the metastatic niche. DOI 10.1242/jcs.259978 ↗
Vassilis Papalazarou · 1 shared paper, 2022 · strength 0.16
- Paper Collagen VI expression is negatively mechanosensitive in pancreatic cancer cells and supports the metastatic niche. DOI 10.1242/jcs.259978 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.